chrisvoncsefalvay/vaers-outcomes huggingface dataset:
had COVID-19 a month ago; This spontaneous case was reported by a nurse and describes the occurrence of COVID-19 (had COVID-19 a month ago) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In April 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In September 2021, the patient experienced COVID-19 (had COVID-19 a month ago). At the time of the report, COVID-19 (had COVID-19 a month ago) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications are provided.  No treatment medications are provided.  Patient reported that the patient had COVID-19 a month ago after receiving the first two Moderna COVID-19 vaccinations 6 months ago. The patient wanted the booster dose now. The nurse wanted to know about the rules they had to follow regarding administration after SARS-COV-2 infection. The case concerns a  female patient of unknown age with no previous relevant medical history, who experienced the unexpected adverse event on especial interest of COVID-19. The event occurred approximately 6 months after the second dose of Spikevax, however, vaccination dates and onset date of event were not disclosure. The rechallenge was unknown since there's no information about the first dose. The benefit-risk relationship of Spikevax is not affected by this report.; Sender's Comments: The case concerns a  female patient of unknown age with no previous relevant medical history, who experienced the unexpected adverse event on especial interest of COVID-19. The event occurred approximately 6 months after the second dose of Spikevax, however, vaccination dates and onset date of event were not disclosure. The rechallenge was unknown since there's no information about the first dose. The benefit-risk relationship of Spikevax is not affected by this report.
pt recv vax 18MAR96 & 6NOV96 pt devel a small vesicular papular rash w/erythematous base on arm & back located strictly on lt side of body;MD felt that the rash was along dermatome & pt could have shingles;
Flu like symptoms (shaking, chills, delirium) injection site irritation (pain at injection site).
Broke out in shingles; This case was reported by a consumer via interactive digital media and described the occurrence of shingles in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, 1 day after receiving Shingles vaccine, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 17-AUG-2022 Reporter's comment: This case was reported by a patient's cousin via interactive digital media. The patient broke out in shingles a day after her doctor told her she needed the shingles vaccine.  The reporter stated stay away from it. Additional Supportive Information: Follow-up would not possible as no contact details were available. This case had been linked with US2022AMR121238 and US2022AMR121183, reported by same reporter.; Sender's Comments:  US-GSK-US2022AMR121238:Same reporter US-GSK-US2022AMR121183:Same reporter - Invalid case
April 1: loss of small patch of corneal epithelium in left eye, upper temporal region.  Eye pain.  Prophylactically treated with Olfloxacin 3x/day for 2 days, and recovered.  Resumed contact lens use 24 hr later.  April 9 eye pain left eye again,  seen by optometric April 10, loss of corneal epithelium upper nasal eye resgion,  start Ofloxacin again.  Monday 4/12 pain, light sensitivity, saw optometrist again, now has turned into a corneal ulcer,  switched to Moxifloxacin 3x/day.  Tuesday 4/13 pain, light sensitivity and vision blurred, increase Moxifloxacin to 4x daily.  Thursday 4/15, corneal ulcer still painful but changed in appearance   saw ophthalmologist,  increase Moxifloxacin to once per hour.  Fri 4/16 extreme dizziness, imbalance soon after getting out of bed and fell down.  mild dizziness continues next 2 days.  Not sure if any of these related to the vaccine but since they started soon after the vaccine thought I should mention it.
About 4 hours after my administered 2nd dose I experienced severe pain in my TMJ mostly on the left but milder on the right. That developed into a bad headache but was relieved with 200mg Motrin in the evening. The following day I experienced flu-like symptoms, chills (I did not take my temperature), muscle joints, fatigue, continued headache and milder pain in my bilateral TMJ. I continue to take Motrin every few hours. I did not experience the TMJ pain with my first dose in January 2021 but I did have mild flushing, flu-like symptoms. I thought I would report this as I have bilateral TMJ implants since 1997.
He got his vaccine, the following morning he woke up with chills, a slight cough and pounding headache.  He did not take anything for his symptoms.  He waited as he did not know what was going on and after a week it did not get better and he ended up in the ER.  He went to Hospital.  He had a COVID vaccine check which came up negative, had a flu test that was negative.  They gave him a CAT Scan and that did not show anything.  They did not have a record at that point that he had a vaccination.  They sent him home and stating that it was some sort of hypertension.  Everything was fine with him prior to the vaccine.  His BP during the ER visit was  224/110.  He was taking his medication faithfully during that time as well.   They did not have the results from Dr. office that he had had a vaccine.  They got his BP down through an IV and never had a problem with his BP after that and the chills went away a week or two later.  The littler persistent cough and the headache never went away.  At that point he went back to his doctors office and told him that maybe he had a brain bleed or aneurysm and suggested for him to have an MRI of his brain and it came back a few days ago that showed nothing.  At that point somebody mentioned that he could have a pinched nerve and went to a chiropractor  and is a well trained one and works in sports medicine, and said he saw no pinched nerve and good movement.  He said that the test he was doing on him could tell that he had something going on his head such as swelling.  He called his doctor today and said that if he had an MRI done would swelling was in his head would it show up, and was told that it should but sometimes not always.  Asked what he needed to do as he continues to take Tylenol and Ibuprofen and nothing has worked.  He mentioned for him to see a neurologist and is going to go to see a neurologist and got a call that they cannot see him until October.  He had to do some finagling to get an appointment in the clinic, and has an appointment next week with him to see if he can get into a neurologist earlier.
This spontaneous report was received from a pharmacist refers to a patient of unknown age and gender. No pertinent medical history was reported. On 13-APR-2015, the patient was vaccinated with improperly stored ZOSTAVAX VIAL (lot # L000450 and expiration date 09-MAR-2015) 0.65 ml once, subcutaneous. No adverse effects reported. No Product Quality Complaint (PQC) was involved. This is one of the several reports received from the same source. Additional information has been requested.
Around 10:30pm I went to bed and broke out in cold chills and was shivering but also was running a fever. Woke up next day around 9am with body aches
Arm was red, hot and swollen, bruised 9-12-15 to 9-22-15 chills, no appetite, fatigue general ill feeling  9-12 - 9-22 itching 9-22-15 to present, not as severe as at beginning.
No additional adverse effects reported; The patient is in the office 7/1/2020 to be administered the third dose of the HPV series, GARDASIL 9; Began HPV series, GARDASIL on 11/23/2015. The patient was administered GARDASIL 9 on 1/11/2016; This spontaneous information has been received from a registered nurse, concerning a 21-years-old male patient. The patient's pertinent medical history, concurrent conditions, previously drug reactions, allergies and concomitant medications were not provided.    On 23-NOV-2015 the patient was vaccinated with quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) for prophylaxis (strength, dose, frequency, lot number, expiration date, route of administration and anatomical location were not reported). On 11-JAN-2016, the patient was vaccinated with the second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (strength, frequency, lot number, expiration date, route of administration and anatomical location were not reported) (interchange of vaccine products).  On 01-JUL-2020, the patient went to the office to receive the third dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) lot number: R024259 with expiration date 30-MAY-2021 (strength, frequency, route of administration and anatomical location were not reported) (inappropriate schedule of product administration).  No adverse effect reported. combinationproductreport: Yes; brandname: GARDASIL 9 SYRINGE (DEVICE); commondevicename: HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: R024259; expirationdate: 30-MAY-2021; deviceage and unit: 0 ; malfunction: Unknown; productavailableforevaluation: No; deviceusage: Unknown; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not suggest a causal association with the device or device constituent
pt came to the office w/a rash all over x 3 days;MD thinks viral exanthem vs MMR reaction;
Flu like symptoms, weakness, unable to walk, chest pains, stomach pains and pains through out body, warm stabbing sensation
SWEATS; CAN'T SLEEP; CHILLS; NOT FEELING OK; FEELS LIKE VOMITING; HEADACHE; This spontaneous report received from a consumer concerned a 21 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 07-APR-2021, Laboratory data included: COVID-19 antigen test (NR: not provided) NEGATIVE. On 08-APR-2021, the subject experienced sweats. On 08-APR-2021, the subject experienced can't sleep. On 08-APR-2021, the subject experienced chills. On 08-APR-2021, the subject experienced not feeling ok. On 08-APR-2021, the subject experienced feels like vomiting. On 08-APR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the headache, chills, sweats, can't sleep, feels like vomiting and not feeling ok was not reported. This report was non-serious.
Shooting pain in shoulder of vaccinated left arm, tingling in left ring and pinky finger. Went to MD 10/28/10, put on course of steroids.
pt recvd vax 18OCT;arm swollen (lt upper) red, very sore 2 days later;p/10 days pt c/o arm still being sore;will be out of town x 4 days & will contact if not improved by then;advised to see MD if necessary
Client tolerated procedure well. Did not state any concerns with vaccine. During waiting period became dizzy hot and rashy area appeared on opposite arm from flu shot and around neck. Face became reddened. Pt recovered with rest, cool compress and laying down x 30min. BP 128/76 WNL.
Rash/redness on arms, flushed in face and tremors in hand where vaccine administered. Severe stomach cramps, fainting, headache leg pain, chills, shakes, fever, aching muscles, frequent urination, feeling of throwing up and general feeling unwell. These symptoms occur 4-5 times per week.
- Tdap (Boostrix) inadvertently administered by staff instead of DTaP (Infanrix).  - As this would be the fourth dose in patient's DTaP series, counted as valid and will be entered into Immune Registry.  - Medical Center administration contacted within hospital guidelines of reporting medical errors/adverse events. Family will be alerted as well.   - Plan to monitor patient at home for any additional reactions
pt recv vax 10OCT96 & w/in approx 1/2 hr pt exp tightness in throat, trouble breathing, flushed face, sweating, & cold spasms in chest;pt mom called MD & was instructed to treat the pt sx w/DPH;
Dizziness, that turned into a Syncopal event, resulting in a fall, that resulted in a broken ankle and concussion.   Transported to nearest hospital, I had to have emergency surgery on left ankle, by Dr.  A plate and screws were placed in my ankle to stabilize the break.  I am being treated and monitored by my general doctor for the concussion.  I am currently non-weight bearing on my ankle, for a minimum of 2-4 weeks.  I am unable to work due to the ankle break and concussion, for an undetermined amount of time. I am scheduled to meet with Dr. on the 4th of March, at which time he stated  he will want to begin physical therapy, once the break has reached an adequate stage of healing.  I will be re-evaluated by my general Dr. for the concussion in 2 weeks.
Paleness, listlessness, and swelling at injection site occurred within 2 hours after injections. Fever of 105 degrees within 5 hours after injections. Rash, projectile vomiting, and diarrhea for 7 months post vaccination.
Redness and swelling to left upper leg. Parent instructed to apply warm packs and message often, also to watch and report any changes.
Expired vaccine used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in an 84-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jun-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 25-Jun-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications information was reported. No treatment medications were provided.  The vaccine was administered after 7 days of first puncture.  The Moderna vaccine was used as though it had preservative, just like flu multi-dose vials.   Most recent FOLLOW-UP information incorporated above includes: On 28-Sep-2021: Follow up received and contains non significant information.
Pain at injection site at 6 hours post-vaccination, headache at 12 hrs, nausea, vomiting, diarrhea at 24 hrs.
Persistent inflammation of both knee joints resulting in erythema, swelling, and pain. Significant limitations in mobility where previously there were no limitations. Symptoms are still persisting 4 months later. Patient now sometimes requires assistance to walk. Concerned that she may need to apply for disability as this has impaired her ability to work.
I am reporting my positive COVID-19 symptoms 04/23/2022. I didn't have a fever, I had really bad of chest congestion, body aches, fatigue, and  headache. I lost my appetite but I didn't lost me taste or smell. I was in bed for about 4 days. My symptoms was moderate. I haven't been sick in years.
no adverse event; multiple patients were vaccinated with an improperly stored vaccine; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapies were not reported.  On 13-JUN-2019, the patient was vaccinated with an improperly stored dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ), 2 ml, orally, LOT# R027157, expiry date 14-JUL-2020 for prophylaxis. The vaccine was exposed to a temperature of 34.2 F for 4 hours and 54 minutes. This call was made because of a digital data logger. There were no previous temperature excursions. No adverse effects were reported.  This is one of several reports from the same reporter.; Sender's Comments:  US-009507513-1906USA011674: US-009507513-1907USA000889: US-009507513-1907USA000882: US-009507513-1907USA000883: US-009507513-1907USA000884: US-009507513-1907USA000885: US-009507513-1907USA000886: US-009507513-1907USA000887: US-009507513-1907USA000888: US-009507513-1907USA000890: US-009507513-1907USA000891: US-009507513-1907USA000892: US-009507513-1907USA000893: US-009507513-1907USA000894: US-009507513-1907USA000895: US-009507513-1907USA000896: US-009507513-1907USA000897: US-009507513-1907USA000898: US-009507513-1907USA000899: US-009507513-1907USA000900: US-009507513-1907USA000901: US-009507513-1907USA000902: US-009507513-1907USA000904: US-009507513-1907USA000905: US-009507513-1907USA000906: US-009507513-1907USA000907: US-009507513-1907USA000908: US-009507513-1907USA000909: US-009507513-1907USA000910: US-009507513-1907USA000911: US-009507513-1907USA000912: US-009507513-1907USA000913: US-009507513-1907USA000914: US-009507513-1907USA000915: US-009507513-1907USA000916: US-009507513-1907USA000917: US-009507513-1907USA000918: US-009507513-1907USA000919: US-009507513-1907USA000920: US-009507513-1907USA000921: US-009507513-1907USA000922: US-009507513-1907USA000923: US-009507513-1907USA000924: US-009507513-1907USA000925: US-009507513-1907USA000926: US-009507513-1907USA000927: US-009507513-1907USA000928: US-009507513-1907USA000929: US-009507513-1907USA000930: US-009507513-1907USA000931: US-009507513-1907USA000932: US-009507513-1907USA000933: US-009507513-1907USA000934: US-009507513-1907USA000935: US-009507513-1907USA000936: US-009507513-1907USA000937: US-009507513-1907USA000938: US-009507513-1907USA000903:
Pt. states that after receiving the 2nd dose of Phizer 11/23/2021, started experiencing symptoms 11/26/2021 of shortness of breath and "pimples" on the left arm. "Pimples" hive-like areas throughout the chest, both arms, and back area.  No noted Primary visit/communications. Pt. still continuing to experience symptoms.
allergic reaction in lips and tong became numb and a funny taste in mouth then hart time breathing; This is a spontaneous report from a contactable consumer (patient). This patient of unspecified age and gender received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) at single dose on 02Apr2021 for COVID-19 immunization. Medical history and concomitant medication were not reported. Patient had an allergic reaction in lips and tong became numb and a funny taste in mouth then hart time breathing. Patient spent 6 hours in the ER at hospital. The outcome of event was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Pain & redness at site, swelling at site 8x6cm. Nausea, vomiting, low grade fever.
sore arm; fatigue; This spontaneous case was reported by a nurse and describes the occurrence of MYALGIA (sore arm) and FATIGUE (fatigue) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 009M2014 and 0391120A) for COVID-19 vaccination.     No Medical History information was reported.   On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MYALGIA (sore arm) and FATIGUE (fatigue). At the time of the report, MYALGIA (sore arm) and FATIGUE (fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Jul-2021, SARS-CoV-2 test: positive (Positive) Positive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not provided. Treatment information was not provided.   This case was linked to MOD-2021-262203 (Patient Link).
This spontaneous report as received from a registered nurse refers to a 22 month old male patient. Medical history and current conditions were not reported. On 07-AUG-2014, the patient was vaccinated with a dose of VARIVAX (Merck) lot # reported as J006106, expiration date: 17-MAY-2015 (route and dose were not reported) that was improperly stored on 04-SEP-2012, 06-NOV-2012, 21-MAR-2013 and 07-AUG-2014. The cumulative excursions were supported. Concomitant medications was not reported. No adverse effect was reported. This is one of several reports from the same source. Additional information has been requested.
Pt received PNEUMOVAX at approx 2:50 PM. That evening developed softball size area of redness, warmth, pain, swelling at inj site (L) deltoid. ALEVE that night, symptoms have improved daily without any further treatment per pt.
Shot (HIB) given on 2/3/2012. Foster mother reports red area around site on 2/14/12. Dx: cellulitis tx: KEFLEX on 2/16/12.
Approx 3 minute after admin - pt. became flushed - redness in face & chest, then c/o sharpness of breath/chest tightness - within 10 minute wheezing, audible - pt. administered EPIPEN - instant symptoms resolved.
The pt experienced a fever of greater than 103 and periods of screaming at night. The fever began a few hours post vax.
Patient received Amevive from MD, for psoriasis AM of 10/28/2003 (IV).  Also had external Oxsoralen ultra treatment that AM (10th or 11th Amevive tx).  Had flu shot about 2-3 hours later.  Approximately 14:00 on 10/28, experienced itching.  When patient got home from work about 17:00, noted hives on legs, trunk, arms and groin.  Felt nervous and took Benadryl x 1 at 18:00.  Minor relief and repeated Benadryl at 21:30.  Slept OK, and reported to our office at about 08:20 10/29/2003.  Currently only feels "drugged" and "head pressure".
Watery Diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er8730) via an unspecified route of administration in the right arm on 28Mar2021 at 12:15 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: En6206) via an unspecified route of administration in the right arm on 07Mar2021 at 14:30 (at the age of 48 years) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Mar2021 at 20:30, the patient experienced watery diarrhea. The patient did not receive any treatment for the event. The clinical outcome of the event watery diarrhea was recovered on an unknown date at the time of this report.   No follow-up attempts are needed. No further information is expected.
Information has been received from a pharmacist concerning a female employee who was vaccinated with a first, second, and third dose of MMR, with the most recent being "6 months ago", in approximately March 2006. "Now", in 2006 the patient had a negative rubella titer. Unspecified medical attention was sought. No product quality complaint  as involved. No other information was provided. Additional information has been requested.
Patient complained of numbness/tingling to left side of face.  No respiratory distress,  CMS intact, no neuro deficits.  Patient feeling better after 30 minute observation.